These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38834088)

  • 21. Neoadjuvant Therapy: When Should It Be Used for Pancreatic Cancer?
    Kelly KN; Macedo FI; Merchant NB
    Adv Surg; 2020 Sep; 54():49-68. PubMed ID: 32713439
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful chemotherapy with modified FOLFIRINOX for pancreatic acinar cell carcinoma.
    Hashimoto M; Hikichi T; Suzuki T; Tai M; Ichii O; Matsuhashi N; Kita E; Takahashi S; Okubo Y; Hakozaki H; Ejiri Y; Ohira H
    Clin J Gastroenterol; 2017 Dec; 10(6):564-569. PubMed ID: 29052123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic Mass and Subcutaneous Nodules.
    Choi SJ; Lee JM; Lee HS
    Gastroenterology; 2019 Feb; 156(3):558-559. PubMed ID: 30296438
    [No Abstract]   [Full Text] [Related]  

  • 24. Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When?
    Kim MP; Katz MHG
    Ann Surg Oncol; 2019 Jun; 26(6):1596-1597. PubMed ID: 30680479
    [No Abstract]   [Full Text] [Related]  

  • 25. In brief: liposomal irinotecan (Onivyde) for pancreatic cancer.
    Med Lett Drugs Ther; 2016 Jun; 58(1496):e76. PubMed ID: 27249099
    [No Abstract]   [Full Text] [Related]  

  • 26. Combination chemotherapy for advanced pancreatic cancer--has its time finally come?
    Kulke MH
    Lancet Oncol; 2005 Jun; 6(6):352-3. PubMed ID: 15948320
    [No Abstract]   [Full Text] [Related]  

  • 27. [Adjuvant gemcitabine plus S-1 chemotherapy for pancreatic cancer after surgical resection - outcomes and future perspectives].
    Murakami Y; Uemura K; Sudo T
    Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1661-9. PubMed ID: 21971141
    [No Abstract]   [Full Text] [Related]  

  • 28. [Systemic chemotherapy for metastatic pancreatic cancer].
    Morizane C
    Nihon Shokakibyo Gakkai Zasshi; 2023; 120(8):651-657. PubMed ID: 37558411
    [No Abstract]   [Full Text] [Related]  

  • 29. [Locally advanced pancreatic carcinoma. Radiochemotherapy prolongs survival].
    Wilkowski R; Heinemann V; Rau H
    MMW Fortschr Med; 2000 Oct; 142(42):31-2. PubMed ID: 11077823
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case report of hepatic arterial infusion chemotherapy and RFA for liver metastasis from pancreatic cancer].
    Nakayama A; Tajima H; Kitagawa H; Shoji M; Nakanuma S; Makino I; Hayashi H; Nakagawara H; Miyashita T; Takamura H; Ohta T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2205-7. PubMed ID: 25731471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined gemcitabine and alpha-interferon therapy for pancreatic cancer: report of a case.
    Sawai H; Okada Y; Tanaka M; Funahashi H; Yamamoto M; Takeyama H; Manabe T
    Dig Dis Sci; 2006 Jul; 51(7):1285-9. PubMed ID: 16944027
    [No Abstract]   [Full Text] [Related]  

  • 32. Contemporary trials evaluating neoadjuvant therapy for resectable pancreatic cancer.
    Chawla A
    J Surg Oncol; 2021 May; 123(6):1423-1431. PubMed ID: 33831254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic advances in metastatic pancreatic adenocarcinoma and related cancers: focus on evidence-based and sequenced approaches to survival extension in metastatic pancreatic adenocarcinoma.
    Bekaii-Saab T; Yu K; Lima CMSR; Wolin EM
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):1-16. PubMed ID: 30807558
    [No Abstract]   [Full Text] [Related]  

  • 34. FOLFIRINOX: a great leap forward, but for whom?
    dos Santos LV; de Andrade DP; Lima JP
    J Clin Oncol; 2012 Jan; 30(1):114-5; author reply 114. PubMed ID: 22124105
    [No Abstract]   [Full Text] [Related]  

  • 35. [Locoregional and systemic therapy of advanced pancreatic carcinoma].
    Gebauer T; Ridwelski K; Fahlke J; Lippert H
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1344-7. PubMed ID: 9931877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options.
    Semaan A; Maitra A
    Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):76-78. PubMed ID: 29317774
    [No Abstract]   [Full Text] [Related]  

  • 37. Leveraging combinatorial chemotherapy to improve outcomes in patients with pancreatic cancer.
    Koniaris LG; Jin X; Montero AJ; Zimmers TA
    Cancer Biol Ther; 2010 Jul; 10(1):108-9. PubMed ID: 20581450
    [No Abstract]   [Full Text] [Related]  

  • 38. Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
    Tempero MA; Behrman S; Ben-Josef E; Benson AB; Cameron JL; Casper ES; Hoffman JP; Karl RC; Kim P; Koh WJ; Kuvshinoff BW; Melvin WS; Muscarella P; Sasson AR; Shibata S; Shrieve DC; Talamonti MS; Tyler DS; Vickers SM; Warren RS; Willett C; Wolff RA;
    J Natl Compr Canc Netw; 2005 Sep; 3(5):598-626. PubMed ID: 16194453
    [No Abstract]   [Full Text] [Related]  

  • 39. Gemcitabine plus cisplatin in advanced pancreatic cancer.
    McWilliams RR; Alberts SR
    J Clin Oncol; 2007 Mar; 25(9):1142; author reply 1142-3. PubMed ID: 17369580
    [No Abstract]   [Full Text] [Related]  

  • 40. Progress in pancreatic cancer: moving beyond gemcitabine?
    Basu B; Jodrell D
    Expert Rev Anticancer Ther; 2012 Aug; 12(8):997-1000. PubMed ID: 23030218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.